Optogenetic Market by product type (light instruments, actuators, sensors), by application (retinal diseases treatment, hearing problems treatment, neuroscience, and others), - Forecast to 2032

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5 GLOBAL OPTOGENETICMARKET, BY PRODUCT TYPE

5.1 LIGHT INSTRUMENTS

5.1.1 LEDs

5.1.2 LASERS

5.2 ACTUATORS

5.2.1 CHANNELRHODOSPIN

5.2.2 HALORHODOSPIN

5.2.3 ARCHAERHODOSPIN

5.3 SENSORS

5.3.1 CALCIUM SENSORS AWQUORIN

5.3.2 CAMELEON

5.3.3 GCaMP

5.3.4 CHLORIDE

5.3.5 MEMBRANE GATED

6. GLOBAL OPTOGENETICMARKET, BY APPLICATION

6.1 NEUROSCIENCE

6.2 RETINAL DISEASES TREATMENT

6.3 HEARING PROBLEM TREATMENT

6.4 BEHAVIORAL TRACKING

6.5 CARDIOVASCULAR ALIGNMENT

6.6 PACING

7. GLOBAL OPTOGENETICMARKET, BY REGION

7.1 INTRODUCTION

7..2 AMERICAS

7.2.1 NORTH AMERICA

7.2.1.2 U.S

7.2.1.2 CANADA

7.2.1.3 SOUTH AMERICA

7.3 EUROPE

7.3.1 GERMANY

7.3.2 FRANCE

7.3.3 ITALY

7.3.4 SPAIN

7.3.5 U.K

7.3.6 REST OF EUROPE

7.4. ASIA-PACIFIC

7.4.1 JAPAN

7.4.2 CHINA

7.4.3 INDIA

7.4.4 REPUBLIC OF KOREA

7.5 MIDDLE EAST & AFRICA

7.5.1 UAE

7.5.2 SAUDI AERBIA

7.5.3 KUWAIT

7.5.4 QATAR

7.5.5 OMAN

8. COMPETITIVE LANDSCAPE

8.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

8.1.1 STRATEGIC PARTNERSHIP

8.1.2 MERGER & ACQUISITION

9 COMPANY PROFILE

9.1 ADDGENE

9.1.1 OVERVIEW

9.1.2 PRODUCT OVERVIEW

9.1.3 FINANCIALS

9.1.4 KEY DEVELOPMENTS

9.2 COBALT INTERNATIONAL ENERGY INC.

9.2.1 OVERVIEW

9.2.2 PRODUCT OVERVIEW

9.2.3 FINANCIALS

9.2.4 KEY DEVELOPMENTS

9.3 COHERENT

9.3.1 OVERVIEW

9.3.2 PRODUCT OVERVIEW

9.3.3 FINANCIALS

9.3.4 KEY DEVELOPMENT

9.4 LASER GLOW TECHNOLOGY

9.4.1 OVERVIEW

9.4.2 PRODUCT OVERVIEW

9.4.3 FINANCIALS

9.4.4 KEY DEVELOPMENTS

9.5 JACKSON LABORATORIES

9.5.1 OVERVIEW

9.5.2 PRODUCT OVERVIEW

9.5.3 FINANCIALS

9.5.4 KEY DEVELOPMENTS

9.6 REGENXBIO INC.

9.6.1 OVERVIEW

9.6.2 PRODUCT OVERVIEW

9.6.3 FINANCIALS

9.6.4 KEY DEVELOPMENTS

9.7 THORLABS

9.7.1 OVERVIEW

9.7.2 PRODUCT OVERVIEW

9.7.3 FINANCIALS

9.7.4 KEY DEVELOPMENTS

9.9 OTHERS